The U.S. government is turning its back on a medical breakthrough that has saved millions of lives, halting $500 million in ...

Non-profit arm of the de-extinction company secures an additional $50 million, expands global projects and partnerships, and ...

Novartis agrees to acquire Avidity Biosciences, an innovator in RNA therapeutics, strengthening its late-stage neuroscience ...

A cutting-edge therapy using base-edited immune cells is offering a major breakthrough for patients with one of the toughest ...

This article and associated images are based on a poster originally authored by Donato Tedesco, Tianbing Liu, Dongfang Hu, Nadya Isachenko, Debbie Deng, Paul Diehl and Alex Chenchik and presented at ...

A cutting-edge base-edited CAR T-cell therapy is opening a revolutionary new frontier for patients battling aggressive T-cell ...

Worsham and Jena are physicians and researchers at Harvard Medical School and the authors of “Random Acts of Medicine: The Hidden Forces That Sway Doctors, Impact Patients and Shape Our Health.” This ...

Flashpoint Therapeutics, a biotechnology company pioneering a new class of structural nanomedicines, today congratulates its scientific co-founder, Professor Chad A. Mirkin, on being awarded the ...

Every major pharmaceutical breakthrough in the past 40 years started with taxpayer-funded basic research: mRNA vaccines, ...

A groundbreaking new treatment using genome-edited immune cells, developed by scientists at UCL (University College London) and Great Ormond Street Hospital (GOSH), has shown promising results in ...